Frizzled related proteins (Frps) are secreted proteins structurally similar to frizzled receptors; they bind Wnt via the cysteine-rich domain and antagonize the Wnt signaling pathway. In this study, we have investigated the mechanisms regulating the transcriptional regulation of rat Frp (rFrp) promoter. From previous findings, we know that the transcriptional activation domain of rFrp resides in the region À202 to À144 relative to the transcription start site, and that it is essential for efficient promoter activity. The study presented here was designed to identify trans-acting factors that bind to this critical domain of the rFrp promoter and to elucidate the pathway involved in the regulation of rFrp expression. Electrophoretic mobility shift assay (EMSA) demonstrated that specific DNAprotein binding activities fall into two adjacent core sequences with (CTTTGGGGG) at À197 to À189 and (AGATGATGTAA) at À151 to À141 of the rFrp promoter. Reporter assay showed that these core sequences are both required for the activation of rFrp promoter. Mutation within either one or both core sequence drastically reduced the promoter activity. Southwestern blotting showed that the estimated molecular mass of the distinct binding protein to the (AGATGATG-TAA) domain is about 43 kDa. Further EMSA suggested CREB as the trans-acting factor in the DNA-protein complex, which was out competed by CREB consensus oligonucleotides and supershifted by anti-CREB antibody. Overexpression of PKA and CREB also transactivated rFrp promoter, and dominant-negative CREB inhibited the promoter activity in transient reporter assays. More importantly, CREB, phosphorylated CREB and the adaptor protein CBP were found binding to the endogenous rFrp promoter using chromatin immunoprecipitation assay. Collectively, our results demonstrate the induction of rFrp promoter activity by PKA and CREB in vitro, and the binding of CREB and CBP to the rFrp promoter core motif in vivo.
Introduction
Frizzled related protein (Frp) belongs to a family of secreted proteins that are structurally related to the frizzled transmembrane proteins (Fz). Frp contains a signal peptide for secretion at the amino-terminus followed by a domain with high sequence homology with the Fz cysteine-rich domain (CRD) (Hoang et al., 1996; Finch et al., 1997; Rattner et al., 1997) . Fz proteins serve as receptors for Wnt family proteins through the extracellular CRD as the Wnt binding site (Bhanot et al., 1996) . Wnt/Fz interaction triggers a series of protein-protein interactions and phosphorylations that lead to the accumulation of b-catenin. High level of cytoplasmic b-catenin facilitates binding with the T-cell factor and lymphoid enhancer factor (Tcf/Lef) transcription factor. The complex then translocates into the nucleus where it acts as a transcriptional activator . Since Frp shares a similar CRD with Fz receptors and competes for Wnt proteins, it acts as an antagonist and interferes with Wnt signaling both in vivo and in vitro (Leyns et al., 1997; Wang et al., 1997; Bafico et al., 1999; Dennis et al., 1999; Uren et al., 2000) . The crystal structures of CRDs from Fz8 and FRP3 have been recently determined, and the CRD surface regions involved in Wnt binding have been mapped (Dann et al., 2001) .
Wnt signaling plays an important role in developmental processes and oncogenesis (Bui et al., 1997; Cadigan and Nusse, 1997; Morin et al., 1997; Brown and Moon, 1998; He et al., 1998; Roose et al., 1999; Tetsu and McCormick, 1999) . The proto-oncogene, c-myc was identified as a downstream target in the Wnt signaling pathway (He et al., 1998) . Cyclin D1 was another target gene regulated by b-catenin in colon carcinoma cells (Tetsu and McCormick, 1999) . The levels of cytoplasmic b-catenin appear to be regulated by the adenomatous polyposis coli (APC) tumor suppressor gene along with GSK-3b and Axin (Novak and Dedhar, 1999) . Inactivation of APC occurred in the early initiation of the human colorectal tumors, and is associated with the aberrant accumulation of b-catenin He et al., 1998) causing enhanced transcriptional activation of genes involved in cell growth control and apoptosis (Peifer, 1997) .
Secretory Frps were independently isolated from bovine, Xenopus, mouse, rat and human by different laboratories (Hoang et al., 1996 ; Leyns et al., 1997; Rattner et al., 1997; Wang et al., 1997; Wolf et al., 1997; Zhou et al., 1998; Chang et al., 1999; Yam et al., 1999; Katoh, 2001 ). The precise interaction of each Frp protein in modulating Wnt signaling remains to be elucidated. Several lines of evidence have shown the involvement of Frp in antagonizing and modulating Wnt signaling. Overexpression of human FRP cDNA has been shown to lead to a decreased expression of bcatenin (Melkonyan et al., 1997) . Interaction between Frzb and Xwnt-8 was evident in coimmunoprecipitation assays, and the axis-inducing activity of an Xwnt-8 in Xenopus embryo has been shown to be blocked by an ectopic expression of Frzb (Leyns et al., 1997; Wang et al., 1997) . These findings support the theory that Frp acts as an antagonist to compete for Wnts in binding to the Fz receptors. The association between Frp and apoptosis has been suggested by several investigators. The rat frpAP was identified as a gene associated with apoptotic processes in the ovary, mammary gland and prostate (Wolf et al., 1997) . Another study suggests that FrzB-2 may be involved in the pathogenesis of human osteoarthritic cartilage through its role in apoptosis (James et al., 2000) . In human myocardium, expressions of sFRP3 and sFRP4 are correlated with the expressions of proapoptotic genes (Schumann et al., 2000) . Until recently, few studies indicated that Frp may play a role in tumorigenesis. Downregulation of Frp expression was observed in multiple human tumors, including those in kidney, breast and ovary and also in mammary carcinoma cell lines (Zhou et al., 1998; Ugolini et al., 1999 Ugolini et al., , 2001 Preiherr et al., 2000; Wong et al., 2002) . In contrast, FrzB has been identified as one of the genes upregulated in primary malignant plasma cells (De Vos et al., 2001) . Frp1 was also found to promote growth of tumor through the antiapoptotic effect (Roth et al., 2000; Fukuhara et al., 2002) . The contradictory roles of Frp proteins in apoptosis and carcinogenesis suggest that different Frps may exert different effects in different tissues or organs. The functional roles of each Frp homologue remain to be elucidated.
As discussed above, Frp is an important protein in the regulating Wnt genes that play central roles in inter-and intracellular signaling, cellular stress responses, cell growth, survival and apoptosis. As such, the specific control of the gene expression is of crucial physiological interest. Moreover, Frp is strategically located upstream of the Wnt signaling pathway and acts as an antagonist in regulating Wnt genes. An intricate balance of the levels of these two genes may be required for normal cellular responses. Indeed, recent evidence showed that Frp modulates Wnt signaling in a biphasic mode, increasing armadillo at low concentrations but reducing it at higher concentrations (Uren et al., 2000) . We are interested in identifying the molecular cue that controls the transcription of Frp genes. At present, most studies on Frp have focused on the downstream effects of Frp, leaving the regulation of Frp expression largely unexplored. In our recent study, we have cloned and sequenced the promoter region of the rFrp (Yam et al., 2001) , a homologue of mouse sfrp4 and a gene found to be abnormally expressed in Rat 6 fibroblasts overexpressing mutant p53 gene (Yam et al., 1999) . Transient reporter assays of serial deletion constructs have identified two critical transcriptional activation domains at nucleotides À202 to À144 of the rFrp promoter region. The region contains two clusters of putative cis-acting elements for STAT3/Lyf-1/MZF1 and C/EBPb/GATA-1 CREB transcriptional factors (Yam et al., 2001) . R613-8 is a cell line in which rFrp is highly expressed and from which rFrp was initially isolated (Yam et al., 1999) . To further understand the transcriptional regulation of rFrp, we have investigated the identity of trans-acting factors that bind to the critical promoter domain (À202 to À144) of rFrp promoter and have elucidated the pathway involved in the regulation of rFrp gene expression. Here, we report the identification of CREB as the trans-acting factor binding to the core sequence (AGATGATGTAA) at À151 to À141. Overexpression of PKA and CREB transactivated rFrp promoter and expression of dominant-negative CREB inhibited the enhanced promoter activity. Chromatin immunoprecipitation (CHIP) with specific anti-CREB antibody further revealed the interaction of both CREB and phosphorylated CREB (p-CREB) to the endogenous rFrp promoter. Importantly, CBP, the transcriptional adaptor, was found to be present in the CRE/CREB complex in vivo. Taken together, our analyses demonstrated the role of CREB in the regulation of rFrp basal promoter activity both in vitro and in vivo.
Results

Detection of nuclear factors binding to the transcriptional activation domain of rFrp
To detect possible nuclear factor binding activity to the transcriptional activation domain resided in À202 to À144 region, we performed an EMSA analysis. PCRamplified Probe (À206/À177) spanning the putative STAT3/Lyf-1/MZF1 cis-acting elements; and Probe (À158/À129) spanning the putative C-EBPb/GATA/ CREB DNA binding elements were separately employed for EMSA assays (Figure 1a ). DNA-protein complex formations between R6 13-8 nuclear extract and the Probes (À206/À177) and (À158/À129) were detected (Figure 1b, c) . As shown, the binding intensity increased as the amount of nuclear extract (0-1 mg) increased. The addition of molar excess of unlabeled probes to the nuclear extracts inhibited formation of these DNA-protein complexes. Also, the binding intensity between nuclear extracts and the (À158/ À129) probe is higher than with the (À206/À177) probe.
Mapping of the core sequence for DNA-protein binding
The above result suggests that specific DNA-protein binding activities fall in the À206 to À177 and À158 to À129 regions. We then attempted to further define the core sequence within these critical regions for DNA-protein interaction. Probes (À200/À183) and (À153/À136) with and without stepwise nucleotide substitutions were used as competitors in competition assays (Figure 2 ). The wild-type probes À206/À177 and À200/À183, and mutant probes M1, M5 and M6 specifically competed off the DNA-protein binding. However, the mutant probes M2, M3 and M4 failed to compete for the DNA-protein complexes, suggesting that the mutated sites in M2, M3 and M4 are essential for the protein-DNA interaction. Using the similar approach, the unlabeled wild-type probes À158/À129 and À153/À136, and mutant probes M7, M11 and M12 almost completely abrogated the DNA-protein interaction, but not with the mutant probes M8, M9 and M10. Competition assays clearly demonstrate that the core nucleotides À197 to À189 (CTTTGGGGG) and À151 to À141 (AGATGATGTAA) are essential for the specific DNA-protein interaction (Figure 2b ).
Mutation in core sequence reduced rFRP promoter activity
To demonstrate that DNA-protein interaction in the core sequence is required for the transcriptional regulation of rFrp, reporter constructs carrying mutated nucleotides were constructed and analysed for promoter activity in R6 13-8 cells. The identified CTTTGGGGG core sequence in Site 1 and AGATGATGTAA core sequence in Site 2 were replaced by the M3 (CTTcccGGG) and M9 (AGATaAaGTAA) sequences, respectively. Site 1 contains three nucleotides substitutions from À194 to À192, while Site 2 contains two nucleotide substitutions in À147 and À145 in the mutant reporter constructs. Reporter constructs carrying either one, or both of the mutant core sequences, Frp (À202/ þ 83) S1m-S2, Frp (À202/ þ 83) S1-S2 m and Frp (À202/ þ 83) S1m-S2 m resulted in drastic reduction in promoter activity ranging from 80 to 84% of the wildtype construct (Figure 3a) . The above results suggested that two core sequences might act cooperatively in regulation. Another two constructs, Frp (À175/ þ 83)S2 and Frp (À175/ þ 83)S2 m, with truncated Site 1, but retaining the wild-type or mutant Site 2 sequence both showed reductions in promoter activities by 61 and 79%, respectively. The Frp (À144/ þ 83) reporter construct in which the core sequence was truncated at À144, that is, with an incomplete core sequence only displayed basal activity as the vector control. To further confirm the positive regulatory effect of Sites 1 and 2 in regulating rFrp promoter activity, new promoter constructs carrying either the duplet of the wild-type 2x(S1-S2) or the duplet of the mutant 2x(S1m-S2 m) were generated and tested for promoter activity (Figure 3b ). The data showed that the construct 2x(S1-S2) produced 40% higher activity than the monomeric wild-type (S1-S2) construct, while the construct with double mutant 2x(S1m-S2 m) displayed similar activity as the monomeric mutant construct S1m-S2 m. From these results, we demonstrated that the specific DNA-protein interaction is located in the core sequence, and the interaction is essential for the rFrp promoter activation in R6 13-8 cells. It is noted that the Frp(À175/ þ 83)S2 construct with deleted S1 site consistently showed higher activity than the construct Frp(À202/ þ 83)S1m-S2 carrying a mutant S1 site (39 vs 21% of the wild type). Deletion of -202 to -176 region might have caused conformational changes of the DNA-protein complex, shown with the putative cis-acting elements. The probes À206/ À177 and À158/À129 spanning the putative cis-acting elements (underlined) were used in the following EMSA. Binding of R6 13-8 nuclear factors to the probes À206 to À177 (b) and À158 to À129 (c) in an EMSA. An increasing amount of R6 13-8 nuclear extract (0-1 mg) was incubated with 20 000 c.p.m. of Identification of CREB as the candidate nuclear factor in the DNA-protein complex Sequence analysis using TFSEARCH software has identified STAT3/Lyf-1/MZF1 (À206 to À177) and C/ EBPb/GATA-1/CREB (À158 to À129) as the potential candidates binding to the core sequence (Yam et al., 2001) . However, probes, GATCC(TTCTGGGAATT) CC, GGAC(TTTGGGAGA)AATGC and GGAC(AG-TGGGGA)AAATGC consensus to STAT3, Lyf-1 and MZF-1 binding domains, respectively, could compete off the DNA-protein complexes in the region À206 to À177 in gel shift assays (data not shown). Anti-STAT3 antibody could not supershift the DNA-protein complex. This negative result implies that unknown factors might participate in this region for transcriptional regulation. To investigate the identity of nuclear factors that bound to the deduced Site 2 core sequence AGATGATGTAA, Southwestern blotting was performed as described under 'Experimental Procedures' to estimate the size of the binding protein (Figure 4 ). R613-8 nuclear extracts were fractionated on gel, transferred to membrane and hybridized with radioactively labeled probes. The wild type probe À158/À129 hybridized to a protein with approximate size of 43 kDa, while the mutant probe M9 spanning the same region did not bind to any protein. To further our identification, we made use of the consensus oligonucleotides of C/EBPb, GATA-1 and CREB as competitors in the competition assay to examine the DNA-protein binding specificity (Figure 5a ). The DNA-protein complex was competed off by 200-fold molar of C/EBPb and CREB consensus sequences (Figure 5b ). In contrast, no competition was observed when using GATA-1 consensus sequence as competitors. This ruled out the possibility that GATA-1 is the protein that binds to the core sequence. The specific DNA-protein complex was supershifted by anti-CREB antibody, suggesting that CREB binds to the core sequence in vitro and plays a role in rFrp regulation. In contrast, the anti-C/EBPb antibody did not alter the mobility of the specific band although C/EBPb consensus sequence competed off the DNA-protein band.
Activation of rFrp promoter activity by exogenous CREB and PKA Identification of CREB binding to the critical core sequence responsible for the rFrp promoter activation led us to question whether CREB is sufficient to activate the rFrp promoter. Phosphorylation of CREB at serine 133 by kinases is an essential step for CREB activation leading to the regulation of gene transcription (Gonzalez and Montminy, 1989) . In order to investigate the role of CREB and protein kinase A (PKA) in the rFrp promoter activation, we transfected the Frp (À202/ þ 83) construct with expression vectors of the catalytic domain of PKA (pKA) and CREB into undifferentiated F9 teratocarcinoma cells that do not respond to cAMP (Gonzalez and Montminy, 1989) . Cotransfection of PKA and CREB elevated rFrp promoter activity by nearly fivefold; in contrast, there was no significant increase in promoter activity when cotransfection was undertaken with PKA and CREB-AS, which is a mutant CREB with alanine substituted for serine133 (Gonzalez and Montminy, 1989) (Figure 6a ). This result strongly suggested that phosphorylation of CREB at serine 133 is required for rFrp promoter activation. It is worth noting that a slightly higher promoter activity was obtained after transfection with CREB-AS in the presence and absence of PKA when compared to PKA alone or the vector control. This may be explained that the CREB-AS, in this study, were weakly activated by phosphorylation of other aminoacid residues located within the critical kinase inducible domain (KID) through other endogenous kinases. There are supporting evidences for our hypothesis (for a review, see Shaywitz and Greenberg, 1999) . To further confirm the CREB-mediated transcription of Frp, constructs Frp(À202/ þ 83)M9 and Frp(À175/ þ 83)M9 devoid of the CREB core sequence were employed in the promoter activity study. Coexpression of PKA and CREB failed to stimulate rFrp promoter activity when using Frp reporter constructs with M9 mutant core sequence, or with truncated core site as in Frp (À144/ þ 83) (Figure 6b ). We also made use of an expression vector, K-CREB, which expresses a form of CREB lacking the DNA binding domain, to determine the role of CREB (Walton et al., 1992) . K-CREB acts as a dominant-negative mutant by interacting with CREB to form an inactive dimer. Overexpression of K-CREB reduced the stimulation of rFrp promoter activity induced by PKA and CREB (Figure 6c ). The promoter activities of Frp (À202/ þ 83) and Frp (À175/ þ 83) constructs were reduced by 60 and 65%, respectively, when 1 mg of K-CREB expression vector was introduced into cells. Figure 3 Nucleotide substitutions within the deduced core sequences reduce rFrp promoter activity. (a) Reporter constructs with mutant sequences showed reduction in promoter activity compared to the corresponding wild-type constructs in which the core sequence remained intact. The boxes represent the deduced core sequences in Site 1 (S1: CTTTGGGGG) and Site 2 (S2: AGATGATGTAA) of the rFrp promoter domain À197 to À189 and À151 to À141, respectively. Opened box and hatched box represent the wild-type and mutant sequences, respectively. Wild-type S1 and S2 sequences were replaced by mutant sequences CTTcccGGG (M3) and AGATaAaGTAA (M9), respectively, which showed impaired binding activities in the previous experiment. R6 13-8 cells were transiently transfected with wild-type or mutant rFrp reporter constructs and assayed for alkaline phosphatase activity. Values are normalized with the luciferase activity and expressed as relative activity to the promoterless basic vector, pSEAP2-B (set as 1). (b) Positive regulatory effect of core sequences S1 and S2 are observed in multimerized reporter constructs Figure 4 Southwestern blotting analysis detects a 43 kDa nuclear factor binding to the Site 2 core sequence of the rFrp promoter. Nuclear extracts from R6 13-8 cells were fractionated on a 12.5% SDS-polyacrylamide gel, blotted to nitrocellulose membrane, and probed with 32 P-labeled probes. Wild-type probe À158/À129 comprised bases of the core sequence, while the mutant M9 probes carried altered bases at À147 and À145. The wild-type probe detects a protein of about 43 kDa and is indicated by an arrow. The positions of the prestained molecular size marker are shown
CREB protein binds to rFrp promoter in vivo
Having demonstrated the involvement of CREB in rFrp gene expression in vitro, we further analysed the in vivo binding of CREB to rFrp promoter by chromatin immunoprecipitation (CHIP) (Boyd et al., 1998) . R6 13-8 cells were cultured and treated with formaldehyde to crosslink the DNA-protein complexes in vivo. Isolated chromatin was sonicated, immunoprecipitated with CREB antibody, and subjected to PCR amplification of rFrp promoter region from À296 to À14 containing the putative CREB binding site ( Figure 7a ).
As shown in Figure 7b , the intensity of PCRamplified bands increased proportionally to the amount of input chromatin. The antibody against CREB could effectively immunoprecipitate the rFrp promoter region was shown by specific amplification of the CREB binding region by PCR. The specific amplification of the region covering the CREB binding site was confirmed by sequencing. In contrast, CHIP assay performed either with C/EBPb or without antibody, resulted in no PCR products. This result demonstrates the association of CREB transcription factor to the endogenous rFrp promoter. To further explore the involvement of phospho-CREB and CBP in the rFrp transcriptional regulation, we conducted CHIP assay using antiphospho-CREB and -CBP antibodies (Figure 7c ). The deduced binding element was also precipitated by both antibodies, suggesting that the 
Discussion
Up to now, little information is available about the cisregulatory elements and trans-acting factors that control Frp expression (Yam et al., 2001) . In this study, we have identified the trans-acting factors that may account for the transactivation of rFrp. Our mobility shift assay demonstrated prominent complex formation between the nuclear extract of R6 13-8 cells and the putative cisacting elements in À158 to À129 region. Mutational analysis has defined the nuclear factor-DNA binding element to be GATGATGTAA at À151 to À141 region. Supershift assay using specific antibody against CREB was performed, and recognized CREB as the factor binding to the core sequence. The functional relevance of CREB in promoter activity of Frp is further supported by in vitro mutational reporter assays and in vivo crosslinking experiments. More importantly, in addition to the CREB protein, the phosphorylated form of CREB and CBP were shown to interact with the endogenous rFrp promoter in vivo by the CHIP assay. The deduced nuclear factor binding site GATGATG-TAA identified in this study seems to be slightly diverged from the consensus cAMP-responsive element (CRE) 5 0 -TGACGTCA-3 0 . However, the Matinspector (Genomatix) search indicated that a CREB/CREBP binding motif, TGATGTAA, is well conserved within our deduced nuclear factor-DNA binding sequence motif, although the search also showed that the CRE consensus sequence TGACGTCA is a preferred binding site for many other CREB and CREB-like proteins. These two motifs share five out of six of the core nucleotides for CREB binding ( Figure 5 ). In addition to the seemingly functional CREB domain, unidentified activity is also found in the region À206 to À177 of the rFrp promoter. The deduced CTTTGGGGG DNAprotein binding core (À197 to À189) (Figure 2a ) contains a common G-rich core of a DNA consensus sequences for NF-kB, but bears no consensus sequence that would be recognized by known transcriptional factors. The data from the reporter assays suggest that this core sequence acts in concert with Site 2 region that contains a functional CREB binding domain, responsible for the positive regulation of rFrp. Mutation of either one or both core sequences could drastically reduce the promoter activity by more than 80% as shown in Figure 3a . This synergistic behavior is reminiscent of the common feature of CREB in response to the growth factor signaling. In which, under most circumstances, CREB is incapable of conferring a response in the absence of cooperating factors, but when together with one or multiple factors, they produced a strong promoter activity (Roesler et al., 1995; Yeagley et al., 1998) . A good example to illustrate the mechanism of CREB/cofactor synergism is the study on the activation of c-fos transcription in response to NGF stimulation that requires the cooperatives of CREB/CRE and the upstream SRF to bind to the SRE (Bonni et al., 1995) . In our case, the upstream CTTTGGGGG core may serve as a binding site for the unidentified cofactor(s), which is required for the full CREB-mediated rFrp promoter activity.
Here, we demonstrated that the CREB site in the rFrp promoter is functional and the CREB protein seems to be essential for the transactivation of the rFrp promoter. We also demonstrated that phosphorylation of CREB is important for rFrp transcription. In human undifferentiated F9 teratocarcinoma cells, we showed that expression construct expressing catalytic domain of PKA was able to activate rFrp reporter constructs with wild-type CREB, but not with the mutant CREB with serine to alanine at 133. This finding suggests that phosphorylation of serine 133 by the cAMP-dependent PKA is essential for the CREB-mediated transcription, as revealed by many other studies in vivo and in vitro. However, treatment of R6 13-8 cells with forskolin in our study (data not shown) did not enhance the level of transcription of the endogenous rFrp assessed by Northern blot analysis. This could be explained by the fact that the CREB protein had reached to an activated state (as evidenced by the intrinsic high level of rFrp transcription in R6 13-8 cells), and further stimulation with cAMP did not have an additional effect on its activation. In the crosslinking assay, the phosporylated Formaldehyde crosslinked chromatin isolated from R6 13-8 cells was immunoprecipitated with antibodies and subjected to PCR as described under 'Experimental Procedures'. PCR products were electrophoresed on a 2% agarose gel and ethidium bromide stained. Input represents 0.001-1% of chromatin applied for immunoprecipitation. The amount of PCR products increased correspondingly with the amount of template DNA applied to PCR. None, C/EBPb, CREB, CREB-P and CBP are samples processed through the procedure with no antibody, anti-C/EBPb, -CREB, -phospho-CREB and-CBP antibodies, respectively. Plasmid is the positive control for PCR using rFrp (À564/ þ 83) reporter construct as template. Water represents the negative control of PCR without DNA template in the reaction CREB was, in deed, found binding to the CRE site of rFrp promoter in vivo in R6 13-8 cells. In the same experiment, the CREB-binding protein, CBP, was also found to be present with the p-CREB/CRE complex. It is known that CBP serves as an adaptor that physically links CREB and other transcriptional factors to the general transcription machinery (Shaywitz and Greenberg, 1999) .
CREB has been involved in the regulation Wnt signaling cascade in several accounts. The stability of b-catenin, the key mediator of Wnt signaling cascade, is regulated by the glycogen synthase kinase-3b (GSK-3b). GSK-3b inhibits CREB, Tef/TCF and other signaling pathways by interference with the binding of the transcriptional factors to the respective sites (Boyle et al., 1991; Rubinfeld et al., 1996; Bullock and Habener, 1998) . Wnt signal inactivates GSK-3b so that b-catenin is not phosphorylated and results in the accumulation of b-catenin. Elevated levels of cytoplasmic b-catenin interact with the Lef/Tcf transcription factor, and then the complex translocates to the nucleus and activates transcription of the target genes Morin et al., 1997) . A CREB site has been reported to collaborate with a Lef/TCF site in the transcriptional regulation of several b-catenin-mediated genes. For example, cyclin D1 promoter activity is regulated by CREB whose transactivation is enhanced by integrin-linked kinase (ILK) and inhibited by GSK3b (D'Amico et al., 2000) . WISP-1 proto-oncogene was identified as a gene upregulated in Wnt1-transformed cells (Pennica et al., 1998) . It was shown to be transcriptionally regulated by Wnt-1 and b-catenin. The CREB site was shown to mediate the b-catenindependent transcriptional activation of the WISP-1 (Xu et al., 2000) . It was proposed that accumulation of cytoplasmic b-catenin might elevate levels of cAMP, which in turn activates PKA to phosphorylate CREB and induces transcription of WISP-1 through the CREB site. Wnt signaling is initiated by the Wnt binding to frizzled receptor, then inactivates GSK-3b and results in high level of b-catenin. Based on the studies mentioned above, inactivation of GSK-3b may facilitate the binding of CREB to CRE and accumulation of b-catenin activates PKA to phosphorylate CREB. Under these consequences, the CREB-mediated genes, such as rFrp may be activated as a result of bcatenin accumulation. Elevated rFrp would increase its chance to interact with Wnt and the downregulation of Wnt would form a tight feedback loop in modulating the Wnt signaling. Thus, the CREB protein, one of the best-studied stimulus-induced transcriptional factors, may serve as an integral part of the Wnt signaling pathway. In summary, we have demonstrated the rFrp promoter activity is regulated by the PKA/CREB pathway. To the best of our knowledge, this is the first study investigating the transcriptional regulation of any Frp gene. These data not only provide important information as to how the rFrp is regulated transcriptionally, it may also reveal a CREB-mediated feedback mechanism by which the Wnt signal pathway is modulated.
Materials and methods
Cell culture
R6 13-8, a p53 val135 -overexpressing cell line was described in detailed in previous studies (Yam et al., 1999) and was grown in Dulbecco's modified Eagle's medium (DMEM) (Life Technologies, Inc.) supplemented with 10% calf serum, penicillin and streptomycin at 371C in a humidified incubator with 5% CO 2 in air. Undifferentiated F9 teratocarcinoma cells were plated on 0.1% gelatin-coated tissue culture plates and were maintained in DMEM supplemented with 10% fetal calf serum.
Nuclear extract preparation
Nuclear extracts were prepared from R6 13-8 cells using the protocol described by (Dignam et al., 1983) with modifications. Cultured cells were washed with PBS and collected by centrifugation at 2500 g for 10 min at 41C. Cells were resuspended in 1.5 packed cell volume (pcv) of buffer A (10 mm HEPES, pH 8.0, 1.5 mm MgCl 2 , 10 mm KCl, 1 mm DTT, 0.1%Nonidet P-40, 2 mg/ml aprotinin and 2 mg/ml leupeptin), and lysed with a glass Dounce homogenizer. The homogenate was centrifuged at 2000 g for 10 min at 41C. The pelleted nuclei were resuspended in 2/3 pcv of buffer C (10 mm HEPES, pH 8.0,1.5 mm MgCl 2 , 25% glycerol, 0.42 m NaCl, 0.2 mm EDTA, 1 mm DTT, 2 mg/ml aprotinin, 2 mg/ml leupeptin and 0.5 mm phenylmethylsulfonyl fluoride (PMSF)) and lysed with a glass Dounce homogenizer. The lysed nuclear fraction was gently stirred with a magnetic stirrer on ice, and then centrifuged at 2000 g for 15 min. The supernatant was dialyzed twice for 4 h against 200 volumes of buffer D (20 mm HEPES, pH 8.0, 100 mm KCl, 20% glycerol, 0.2 mm EDTA, 1 mm DTT and 0.5 mm PMSF). The dialysate was centrifuged at 15 000 g for 20 min at 41C to remove the precipitate. Protein concentrations were determined using Bradford assay reagent (Bio-Rad).
EMSA
The doubled-stranded probes were synthesized as complementary oligonucleotides (Table 1) (Table 1) prior to the addition of radiolabeled probe. To perform supershift assays, nuclear extracts were incubated with 0.5-1.0 mg of anti-C/EBPb, anti-CREB (Santa Cruz Biotechnology) or anti-phospho-CREB (New England Biolabs) antibody for 30 min on ice prior to the addition of 32 P-labeled probe. DNA-protein complexes were resolved by electrophoresis for 3 h at 200 V on a 6% polyacrylamide gel in 1 Â TBE. After electrophoresis, the gel was dried and autoradiographed at À801C.
Reporter gene constructs and expression vectors
Promoter sequences with specific nucleotide substitutions were generated by three-step PCR using primers (M3-F, M3-R, M9-F and M9-R as shown in Table 1 ) carrying mutant nucleotides. The resulting mutated fragments were ligated to pSEAP2-B.
The end points and sequences for all plasmids were determined and confirmed by sequencing using BigDyet Terminator kit (PE Biosystems). The DNA plasmids for transfection were prepared by using the QIAGEN Plasmid Purification kit. The expression vectors encoding the wild-type CREB (CMV/ CREB), CREB mutated at serine 133 (CMV/CREB-AS) and PKA catalytic subunit (CMV/pKA) were kindly provided by Dr SC Lin. The dominant-negative CREB expression vector (pCMV-K-CREB) was given by Dr KWK Tsim.
Transient transfection and reporter assay R6 13-8 cells were transfected with 0.5 mg of Frp reporter construct carrying different lengths of Frp promoter sequence from À202 to À144 with or without mutant core sequence (À151 to À141), as well as 0.2 mg of control luciferase plasmid pGL2-C (Promega) for normalization of transfection efficiency. For cotransfection studies, undifferentiated F9 cells were transfected with 0.5 mg of Frp reporter construct with 0.5 mg of CMV/pKA and/or 0.5 mg of CMV/CREB or CMV/ CREB-AS. The empty vector pcDNA3 was used to maintain equal amounts of plasmid DNA for each transfection. To investigate the effect of dominant effect of CREB, increasing amount (0-1 mg) of pCMV-K-CREB was transfected with 0.5 mg of each CMV/CREB, CMV/pKA and Frp promoter construct into undifferentiated F9 cells. DNA transfection and reporter assays were performed as previously described (Yam et al., 2001) .
Southwestern blotting
Nuclear extracts of 60 mg were resolved on a 12.5% SDSpolyacrylamide gel and transferred onto a nitrocellulose membrane. Following transfer, the membrane was blocked overnight at 41C with 2.5% (w/v) nonfat dried milk in hybridization buffer (25 mm HEPES, pH 8.0, 1 mm DTT, 10% (v/v) glycerol, 50 mm NaCl and 1 mm EDTA). The membrane was then incubated with [g-32 P]ATP-labeled probe (À158/À129) or mutant M9 probe and 10 mg/ml salmon sperm DNA as competitor with 0.25% (w/v) nonfat dried milk in hybridization buffer for 4 h at room temperature. The membrane was finally washed with wash buffer (10 mm Tris, pH 7.5, 1 mm DTT, 50 mm NaCl and 1 mm EDTA), dried and autoradiographed.
Chromatin immunoprecipitation
R6 13-8 cells were formaldehyde crosslinked and immunoprecipitated as described (Legros et al., 2001 ) with slight modifications. R6 13-8 cultures were fixed by the addition of formaldehyde at a concentration of 0.4% for 15 min. The reaction was stopped with 0.125 m glycine for 20 min. The cells were scraped and washed with cold PBS and collected by centrifugation. Pelleted cells were resuspended and lysed in 2 ml of cell lysis buffer (5 mm PIPES-KOH, pH 8.0, 85 mm KCl, 0.5% (v/v) Nonidet P-40, 100 ng/ml leupeptin, 100 ng/ml aprotinin and 1 mm PMSF), incubated on ice for 20 min and then dounced. Nuclei were recovered by centrifugation at 3500 r.p.m. for 10 min and resuspended in 200 ml of nuclear lysis buffer (1% SDS, 10 mm EDTA, 50 mm Tris, pH 8.0) containing protease inhibitors. The lysate was sonicated eight times at 10 s each time on ice to shear the chromatin to about 500 bp in length, cleared by centrifugation and diluted 10-fold in immunoprecipitation buffer (1% Triton X-100, 16.7 mm Tris, pH 8.0, 1.2 mm EDTA, 167 mm NaCl) containing protease inhibitors. Chromatin solution was precleared with protein G-sepharose for 1 h at 41C. Precleared chromatin solution was incubated with 20 mg sonicated salmon sperm DNA, protein G-sepharose and 10 mg of anti-C/EBPb, -CREB, -phospho-CREB or CBP antibody, or without antibody and rotated overnight at 41C. The supernatant of the 'no antibody' sample was saved and the chromatin was recovered as the total chromatin input for immunoprecipitation. The beads were washed four times with 1 ml washing buffer (0.1% Triton X-100, 20 mm Tris, pH 8.0, 150 mm NaCl and 2 mm EDTA) and eluted by three successive 5-min incubations with 150 ml of elution buffer (1% SDS and 50 mm NaHCO 3 ). Three fractions of eluates were combined, 1 ml of RNase (10 mg/ml) was added and NaCl was adjusted to a final concentration of 0.3 m. Crosslinking was reversed by heating at 651C for 4 h, followed by the addition of 10 ml of 0.5 mm EDTA, 10 ml of 2 m Tris, pH 6.8, and 2 ml of proteinase K (20 mg/ml). The sample was incubated at 451C for 2 h, and DNA was then extracted by phenol chloroform extraction followed by ethanol precipitation. The DNA pellet was resuspened in 50 ml of H 2 O and 2 ml was used for PCR analysis. Primers CREB-IP-F and CREB-IP-R were designed to amplify the Frp promoter region À296 to À14 spanning the putative CREB binding site. The PCR products were separated on a 2% agarose gel and visualized by ethidium bromide staining. 
